News
Pharmalittle: We’re reading about Sarepta conceding to the FDA, the U.S. transplant system, and more
Sarepta Therapeutics reversed course and agreed to halt all shipments of Elevidys, its gene therapy for Duchenne muscular ...
Sarepta Therapeutics refused a FDA request to halt shipments of Elevidys, its gene therapy for Duchenne muscular dystrophy ...
Sarepta will halt all shipments of Elevidys, its drug for Duchenne muscular dystrophy patients, by Tuesday evening.
Since 2008, Central Illinois Business Magazine's Forty Under 40 awards — powered by Busey Bank — have celebrated the men and women who make our community go. Deadline for nominations for our 18th ...
For thousands of years sirens have lured sailors, haunted coastlines—and shapeshifted through myth and media. Here's how they ...
Families of missing loved ones face a unique and agonizing grief called ambiguous loss. Experts explain this as the pain of ...
Warning for strong winds and rough seas. Issued by the Natural Hazards Early Warning Centre at 10.00 a.m. on 22 July 2025 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results